Research

Retatrutide Verification Checklist 2026 | Artemis Labs

Posted on by administrator

Retatrutide Verification Checklist

10-Point Quality Verification for Triple-Agonist Research Compounds

Field-tested due-diligence framework for researchers acquiring research-grade retatrutide — third-party HPLC + MS, batch-specific COA review, and supplier-compliance red flags. Research use only.

Research Highlights (May 2026 update)

  • Why this checklist matters: Independent re-testing surveys documented ~47% failure rates across research-market retatrutide lots in 2025–2026. Verification is non-optional.
  • Anchor citation: Retatrutide Phase 2 — Jastreboff et al., NEJM 2023, PMID 37366315 (up to ~24.2% at 48 weeks, 12 mg). TRIUMPH-4 Phase 3 protocol published Jan 2026 (DOM, PMID 41090431); Phase 3 efficacy results pending peer review.
  • Defensive posture: Any third-party content citing specific TRIUMPH-4 Phase 3 weight-loss percentages should be treated as fabricated until peer-reviewed Phase 3 readout publishes.

For research-use only. Not for human consumption. These statements have not been evaluated by the FDA. Last updated: May 20, 2026.

Introduction

Retatrutide is a frontier metabolic research compound: a novel triple-agonist targeting GLP-1, GIP, and Glucagon receptors simultaneously. Because this compound is:

  • New (first-in-class triple receptor agonism; Phase 2 published 2023, Phase 3 ongoing)
  • Highly expensive ($400-700/gram)
  • Complex to synthesize (multiple active sites)
  • Subject to supply constraints

Quality verification is critical. Small synthesis errors or impurities dramatically affect research outcomes and data validity.

This checklist ensures you receive authentic, high-quality retatrutide. Use it for every supplier and every order.

The 10-Point Verification Framework

1. MOLECULAR WEIGHT CONFIRMATION (MW = 4541.2 Da)

What it means: Retatrutide has a specific, unique molecular weight. MS analysis must confirm exactly this value (±0.05 Da tolerance).

Why it matters:
– Wrong MW = wrong compound or impurities
– Triple-agonist structure is complex; errors are detectable by MS
– MW is the first proof the compound is correct

What to look for on COA:
– [ ] Mass spectrometry shows parent ion peak
– [ ] Peak located at exactly 4541.2 Da (±0.05 Da)
– [ ] Peak represents >95% of total ions
– [ ] Method specified (ESI-MS, MALDI-MS, or LC-MS)
– [ ] Lab performing MS clearly identified

How to verify if you have equipment:
– Run your own ESI-MS or LC-MS
– Compare peak to literature standard
– If off by >0.1 Da = return to supplier immediately

Red Flags:
– MW not specified on COA
– MW outside expected range (4541.0-4541.5 Da)
– MS data missing or poorly explained
– “Estimated” MW instead of measured
– Peak fragmentation pattern not shown

Quality Score: Pass/Fail (non-negotiable)

2. HPLC PURITY ≥98%

What it means: High-Performance Liquid Chromatography measures what percentage of your compound is pure retatrutide vs. synthesis byproducts.

Why it matters:
– 98% pure = 2% impurities (acceptable)
– 95% pure = 5% impurities (concerning for research)
– 90% pure = unusable (10% unknown compounds)
– Impurities interfere with research results

What to look for on COA:
– [ ] HPLC purity percentage clearly stated (e.g., “98.7%”)
– [ ] Purity ≥98% (minimum acceptable threshold)
– [ ] Specification listed (should be 98% minimum)
– [ ] Result marked “PASS” or meets specification
– [ ] Chromatogram provided or peak areas documented
– [ ] Method details included (column type, solvent system, detection method)

How to verify if you have equipment:
– Run HPLC comparison to your supplier’s data
– Results should be within 1% (98.7% vs. 98.5% acceptable)
– If differ by >2% = data integrity concern

Red Flags:
– Purity <95% (unacceptable)
– Purity not specified
– HPLC data missing
– Same purity across multiple batches (unlikely; variation expected)
– No specification listed (implies no QC standard)

Quality Score: Pass (≥98%) / Marginal (95-97%) / Fail (<95%)

3. BATCH-SPECIFIC (NOT GENERIC) COA

What it means: Each batch you purchase has its own unique COA with that batch’s test results—not a template that applies to “all retatrutide batches.”

Why it matters:
– Generic COAs hide quality variation between batches
– Batch-specific COAs prove your batch was actually tested
– Retatrutide synthesis varies; each batch must be verified
– Generic COAs are red flag for quality shortcuts

What to look for:
– [ ] Batch number clearly printed on COA (e.g., “RTD-2026-04-A1”)
– [ ] Batch number matches your vial label exactly
– [ ] COA date is recent (within 30 days of your purchase)
– [ ] COA is unique (different batch # = different COA)
– [ ] Test results are specific (not “typical” or “expected”)
– [ ] Batch-specific data for each test (MW, purity, endotoxin)

How to verify:
– [ ] Compare COA batch # to vial label batch #
– [ ] Request COA for a different batch from supplier
– [ ] Confirm that COA differs from your COA
– [ ] Check dates: COA should be recent, not months old

Red Flags:
– Batch number missing
– Generic statement like “Certificate applies to all retatrutide from Lot X”
– Same COA results for 5+ different batches (impossible)
– COA dated months before your purchase (stale data)
– Batch number on vial doesn’t match COA
– “Typical values” instead of batch-specific results

Quality Score: Pass (batch-specific) / Fail (generic)

4. THIRD-PARTY TESTING LAB NAMED & VERIFIABLE

What it means: An independent laboratory (not the supplier’s own lab) performed the testing and is willing to be contacted about it.

Why it matters:
– Supplier-only testing can hide quality issues
– Third-party lab provides objective verification
– You can contact lab independently to confirm results
– Accountability requires transparency

What to look for on COA:
– [ ] Testing lab name clearly stated (e.g., “Analytical Labs International”)
– [ ] Lab address and contact info provided
– [ ] Lab is third-party/independent (not subsidiary of supplier)
– [ ] Lab credentials listed (ISO 17025, accreditations)
– [ ] Lab website and phone number functional
– [ ] You can verify lab independently

How to verify:
1. Copy lab name and address from COA
2. Search Google: “[Lab Name] + [Address]”
3. Verify lab exists and is credible
4. Call lab directly: “Can you confirm you tested batch RTD-2026-04-A1?”
5. Lab should be able to: Retrieve records, confirm results, discuss methodology

Red Flags:
– Lab name vague (“Certified Lab” or “Quality Testing”)
– Lab address doesn’t exist
– Lab phone number disconnected
– Lab cannot be reached or found online
– Lab denies knowledge of testing
– Only supplier’s internal lab listed as tester
– Lab is supplier subsidiary (not truly independent)

Quality Score: Pass (third-party verified) / Marginal (supplier-partnered lab) / Fail (supplier-only testing)

5. MS CONFIRMATION OF TRIPLE-AGONIST STRUCTURE

What it means: Mass spectrometry not only confirms molecular weight (Checkpoint 1) but also shows the fragmentation pattern consistent with the triple-agonist structure.

Why it matters:
– MW alone isn’t enough (could be different compound with same MW)
– MS fragmentation pattern is unique to retatrutide’s specific structure
– Triple agonist has 3 distinct binding domains; MS confirms all present
– Fragmentation pattern proves amino acid sequence integrity

What to look for on COA:
– [ ] MS spectrum shows parent ion at 4541.2 Da
– [ ] Spectrum shows expected fragment peaks
– [ ] Major fragments labeled and explained
– [ ] Fragmentation pattern consistent with literature references
– [ ] Chromatogram or spectra image included
– [ ] Mass analyzer type specified (Q-TOF, Orbitrap, etc.)

How to verify (if you have MS access):
– Compare your MS fragmentation to COA
– Should show 3+ major fragment peaks (from triple-agonist structure)
– Patterns should be identical or extremely similar
– If fragmentation differs = contamination or wrong compound

Expected Fragmentation Pattern (Reference):
Retatrutide should show major fragments from:
– GLP-1 receptor binding domain
– GIP receptor binding domain
– Glucagon receptor binding domain

Red Flags:
– MS spectrum not provided
– Only molecular weight given (no fragmentation)
– Fragmentation pattern doesn’t match literature values
– Fragmentation suggests missing domains
– MS method not specified
– Spectrum appears copied (identical to another batch’s)

Quality Score: Pass (full MS with fragmentation) / Marginal (MW only) / Fail (no MS data)

6. ENDOTOXIN TESTING INCLUDED & RESULTS <10 EU/mg

What it means: Test shows bacterial toxin levels. Retatrutide must have <10 EU/mg endotoxin for research safety.

Why it matters:
– Endotoxins trigger immune responses in cell cultures and animal models
– Contaminated batches produce false research results
– High endotoxin can invalidate your entire study
– Endotoxin testing is standard for quality compounds

What to look for on COA:
– [ ] Endotoxin testing clearly documented
– [ ] Result stated as “< X EU/mg” (e.g., “<5 EU/mg”)
– [ ] Result is <10 EU/mg (acceptable)
– [ ] Test method specified (LAL test standard)
– [ ] Limit of detection stated
– [ ] Test date recent (within 30 days)
– [ ] Lab performing test identified

Acceptable Endotoxin Levels:
– <5 EU/mg = Excellent (preferred)
– 5-10 EU/mg = Acceptable (standard)
– 10-50 EU/mg = Concerning (marginal quality)
– >50 EU/mg = Unacceptable (do not use)

How to verify:
– Compare endotoxin result to specification (<10 EU/mg required)
– If above specification, contact supplier
– Ask supplier: “Why is endotoxin at this level?”
– Request retest if borderline

Red Flags:
– Endotoxin testing not performed
– Result >10 EU/mg
– “Not detected” without actual limit stated
– Endotoxin data missing from COA
– Same endotoxin level across all batches (suspicious)

Quality Score: Pass (<10 EU/mg) / Marginal (10-50 EU/mg) / Fail (>50 EU/mg or not tested)

7. APPEARANCE MATCHES SPECIFICATION (White Lyophilized Powder)

What it means: Retatrutide should arrive as a white or off-white lyophilized (freeze-dried) powder with no visible contamination.

Why it matters:
– Color changes indicate degradation, contamination, or synthesis errors
– Clumping suggests moisture absorption (degradation)
– Discoloration suggests oxidation (loss of potency)
– Physical appearance is first visual quality check

What to look for:
– [ ] Appearance description on COA states “white lyophilized powder” or “off-white powder”
– [ ] No discoloration noted (no yellowing, browning, or graying)
– [ ] No clumping or crystallization mentioned
– [ ] Powder is dry (not oily or wet)
– [ ] Appearance consistent with previous batches
– [ ] Description matches what you actually see

When you receive the vial:
1. Open vial carefully (avoid moisture exposure)
2. Observe powder color: Should be white or pale off-white
3. Check for clumping: Should be fine powder or easily resuspendable
4. Verify against COA: Does actual appearance match description?
5. Store properly: Immediately freeze at -80°C

Red Flags:
– Powder is yellow, brown, gray, or discolored
– Clumping or crystallization visible
– Powder appears oily or wet
– Appearance differs significantly from COA
– Vial was improperly sealed (moisture contamination)
– Appearance changed from previous batch

Quality Score: Pass (white powder, normal) / Marginal (slight discoloration) / Fail (significant discoloration/clumping)

8. STORAGE & STABILITY DOCUMENTATION PROVIDED

What it means: Supplier provides clear guidance on how to store retatrutide to maintain quality and potency.

Why it matters:
– Improper storage destroys retatrutide
– Temperature, light, and humidity all affect stability
– Stability data shows how long compound remains potent
– Storage instructions protect your investment

What to look for:
– [ ] Storage temperature specified (should be -20°C minimum, -80°C preferred)
– [ ] Light protection recommended (light-sensitive compound)
– [ ] Humidity requirements stated (low humidity, desiccant)
– [ ] Shelf life documented (e.g., “Stable 2 years at -80°C”)
– [ ] Stability data provided or referenced
– [ ] Reconstitution guidance (if applicable)
– [ ] Freeze-thaw tolerance specified (how many cycles acceptable)

How to store properly:
– Primary storage: -80°C freezer (preferred)
– Alternative: -20°C freezer (acceptable, shorter shelf life)
– Light: Store in amber/dark vial or wrapped in foil
– Humidity: Use desiccant packs in storage container
– Cycles: Minimize freeze-thaw cycles (<5 recommended)

Red Flags:
– No storage instructions provided
– Room temperature storage recommended (incorrect)
– No shelf life information
– Stability data missing
– Instructions conflict with industry standard

Quality Score: Pass (detailed storage documentation) / Marginal (basic instructions) / Fail (no storage guidance)

9. SUPPLIER PROVIDES PUBLISHED RESEARCH REFERENCES

What it means: Supplier can point you to published scientific literature studying retatrutide or its triple-agonist mechanism.

Why it matters:
– Legitimate suppliers support research literature
– Published research validates compound efficacy
– References help you understand mechanistic basis
– Academic references indicate supplier credibility

What to look for:
– [ ] Supplier provides reference list with retatrutide or triple-agonist studies
– [ ] References are to peer-reviewed journals
– [ ] References include the Jastreboff Phase 2 trial (NEJM 2023, PMID 37366315) — the canonical published retatrutide efficacy data
– [ ] References include the TRIUMPH-4 Phase 3 protocol paper (DOM Jan 2026, PMID 41090431)
– [ ] Multiple independent research groups cited
– [ ] References are recent (2023–2026)
– [ ] You can access references independently
– [ ] No “TRIUMPH-4 results” / “RECHARGE trial” / “23.7% / 28.7%” Phase-3-style claims — those are unverified or fabricated

Key references to look for:
– Jastreboff et al., Triple-hormone-receptor agonist retatrutide for obesity — A phase 2 trial. NEJM 2023. PMID 37366315. (Anchor reference.)
– TRIUMPH-4 Phase 3 protocol — Diabetes Obesity & Metabolism, January 2026. PMID 41090431. (Protocol only; Phase 3 efficacy results pending publication.)
– GLP-1/GIP/Glucagon biology reviews (2023–2026)
– Triple-agonist mechanism papers

How to verify:
1. Ask supplier: “What published research supports retatrutide?”
2. Supplier should provide: At least 5-10 citations
3. Verify references: Search PubMed/Google Scholar
4. Read abstracts: Confirm they discuss retatrutide/triple-agonist
5. Note: Supplier should cite independent research, not only their own studies

Red Flags:
– Supplier has no references to provide
– References are to unpublished/proprietary research only
– References are very old (>5 years, inappropriate for new compound)
– All references are from supplier’s own studies
– References don’t actually mention retatrutide
– Cannot independently verify references

Quality Score: Pass (multiple published references provided) / Marginal (few references, mostly from supplier) / Fail (no references or references don’t verify)

10. RESEARCH-ONLY LABELING PRESENT

What it means: Vial label and all packaging clearly state “For Research Purposes Only” and exclude medical/therapeutic claims.

Why it matters:
– Legal requirement in most jurisdictions
– Protects you and supplier from regulatory issues
– Proper labeling ensures compound intended for research use
– Verification of legal compliance

What to look for on vial and packaging:
– [ ] Label states “For Research Purposes Only” clearly
– [ ] No therapeutic or medical claims present
– [ ] Does not suggest use in humans
– [ ] Does not make disease treatment claims
– [ ] Batch number on label
– [ ] Supplier name and contact on label
– [ ] Content (e.g., “Retatrutide 1 mg/mL, 10 mL”) specified
– [ ] Date of manufacture or expiration

What should NOT be present:
– ❌ “For human consumption”
– ❌ “Approved for medical use”
– ❌ “Treats [disease]” or “Heals [condition]”
– ❌ “For injectable use”
– ❌ “Alternative to pharmaceutical [compound]”
– ❌ Medical/therapeutic language

How to verify:
– Carefully read entire label
– Check all packaging materials
– Confirm language is research-only throughout
– Verify consistent across all documents

Red Flags:
– Missing “Research Purposes Only” label
– Therapeutic or medical language present
– Suggests human use or administration
– Label appears to be for a pharmaceutical product
– Language implies medical benefit

Quality Score: Pass (proper research-only labeling) / Fail (missing or improper labeling)

SCORING YOUR SUPPLIER: Verification Checklist

For each of the 10 criteria, assign a score:

PASS (2 points): Criterion fully met, no concerns
MARGINAL (1 point): Criterion mostly met but some concerns
FAIL (0 points): Criterion not met, disqualifying issue

Scoring Matrix

Criterion Score
1. MW = 4541.2 Da ± 0.05 ___
2. HPLC Purity ≥98% ___
3. Batch-Specific COA ___
4. Third-Party Lab Verified ___
5. MS Structure Confirmation ___
6. Endotoxin <10 EU/mg ___
7. Appearance (White Powder) ___
8. Storage Documentation ___
9. Research References Provided ___
10. Research-Only Labeling ___
TOTAL SCORE ___ / 20

Interpretation

18-20 (Excellent): Premium supplier, proceed with confidence
16-17 (Good): Acceptable supplier, no major concerns
14-15 (Marginal): Acceptable with reservations, request clarification
12-13 (Concerning): Address weak areas before purchasing
<12 (Unacceptable): Do not purchase from this supplier

Before Your First Retatrutide Order: Action Plan

Week 1: Supplier Evaluation

  • [ ] Identify 2-3 potential suppliers
  • [ ] Request full specifications and COAs for each
  • [ ] Run verification checklist on each supplier
  • [ ] Score each supplier (this document)
  • [ ] Select top-scoring supplier

Week 2: Pre-Order Communication

  • [ ] Email supplier: “Planning to order retatrutide for research”
  • [ ] Ask about: batch timeline, pricing, bulk options
  • [ ] Request: sample COA, storage instructions, references
  • [ ] Clarify: specifications you require (concentration, quantity)
  • [ ] Verify: third-party testing lab contact information

Week 3: Order Placement

  • [ ] Place initial small order (10-20 mg)
  • [ ] Request: batch-specific COA to be provided upon shipment
  • [ ] Confirm: shipping method (temperature controlled)
  • [ ] Provide: delivery address and contact info

Upon Receipt: Quality Verification

Immediately (within 1 hour):
– [ ] Open vial and verify batch number on label
– [ ] Visually inspect appearance (compare to COA)
– [ ] Check packaging integrity (no damage)
– [ ] Review COA for completeness

Within 1 day:
– [ ] Verify all 10 checklist items against COA
– [ ] Contact third-party lab to confirm testing
– [ ] If any concerns, photograph documentation and contact supplier
– [ ] Store properly immediately (-80°C preferred)

Within 1 week:
– [ ] Run small test dose/assay in your system
– [ ] Verify compound activity matches expected
– [ ] If satisfactory, document supplier for future use

When to Request Refund/Replacement

Automatic rejection (request refund/replacement):
– Molecular weight not 4541.2 Da ± 0.05
– HPLC purity <95%
– Generic COA (not batch-specific)
– Endotoxin >50 EU/mg
– Obvious contamination/discoloration
– Third-party lab cannot verify testing

Request clarification first:
– Purity 95-97% (acceptable if this is all available)
– Endotoxin 10-50 EU/mg (marginal, but usable)
– Minor labeling issues
– Storage documentation incomplete

About Artemis Labs

At Artemis Labs, every retatrutide batch is subjected to rigorous quality verification:

✓ Checkpoint 1: Molecular weight = 4541.2 Da ± 0.05 (MS confirmed)
✓ Checkpoint 2: HPLC purity ≥98% (batch-specific)
✓ Checkpoint 3: Batch-specific COA with unique batch number
✓ Checkpoint 4: Third-party lab testing (fully independent, verifiable)
✓ Checkpoint 5: MS fragmentation pattern documented (triple-agonist structure confirmed)
✓ Checkpoint 6: Endotoxin <5 EU/mg (tested)
✓ Checkpoint 7: Appearance verified (white lyophilized powder)
✓ Checkpoint 8: Comprehensive storage guidance provided
✓ Checkpoint 9: Published research references provided
✓ Checkpoint 10: Research-only labeling on all vials

We understand retatrutide’s significance to your research. Every batch passes all 10 verification checkpoints before shipment.

Use this checklist to evaluate any supplier—including us. We’re confident we’ll score 18-20 consistently.

Questions About Retatrutide Quality?
Email research@artemislabs.com or call our technical support team.

Related Guides:
– Research Peptide Starter Guide (comprehensive introduction)
– COA Interpretation Quick Reference (understand test data)
– Weight Loss Peptide Comparison Chart (retatrutide vs. alternatives)
– Supplier Evaluation Checklist — general vendor assessment

Last Updated: May 20, 2026 (scrubbed of TRIUMPH-4 Phase 3 fabrications; anchored on verified PMID 37366315 + PMID 41090431)
Verification Checklist Version: 2.1

This guide is for research purposes only. All compounds must be handled according to institutional safety protocols. Not for human consumption. These statements have not been evaluated by the FDA.

administrator

Leave a Reply

Your email address will not be published. Required fields are marked *